Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Analysis of the prognostic utility of the cell cycle progression (CCP) score generated from needle biopsy in men treated with definitive therapy.
Canter DJ, Freedland S, Rajamani S, Latsis M, Variano M, Halat S, Tward J, Cohen T, Stone S, Schlomm T, Bishoff J, Bardot S. Canter DJ, et al. Among authors: bishoff j. Prostate Cancer Prostatic Dis. 2020 Mar;23(1):102-107. doi: 10.1038/s41391-019-0159-9. Epub 2019 Jun 27. Prostate Cancer Prostatic Dis. 2020. PMID: 31243337 Free PMC article.
Personalizing Localized Prostate Cancer: Validation of a Combined Clinical Cell-cycle Risk (CCR) Score Threshold for Prognosticating Benefit From Multimodality Therapy.
Tward JD, Schlomm T, Bardot S, Canter DJ, Scroggins T, Freedland SJ, Lenz L, Flake DD 2nd, Cohen T, Brawer MK, Stone S, Bishoff J. Tward JD, et al. Among authors: bishoff j. Clin Genitourin Cancer. 2021 Aug;19(4):296-304.e3. doi: 10.1016/j.clgc.2021.01.003. Epub 2021 Jan 19. Clin Genitourin Cancer. 2021. PMID: 33608228 Free article.
Prognostic utility of biopsy-derived cell cycle progression score in patients with National Comprehensive Cancer Network low-risk prostate cancer undergoing radical prostatectomy: implications for treatment guidance.
Tosoian JJ, Chappidi MR, Bishoff JT, Freedland SJ, Reid J, Brawer M, Stone S, Schlomm T, Ross AE. Tosoian JJ, et al. Among authors: bishoff jt. BJU Int. 2017 Dec;120(6):808-814. doi: 10.1111/bju.13911. Epub 2017 Jun 11. BJU Int. 2017. PMID: 28481440
Prognostic capabilities and clinical utility of cell cycle progression testing, prostate imaging reporting and data system, version 2, and clinicopathologic data in management of localized prostate cancer.
Morris DS, Woods JS, Edwards B, Lenz L, Logan J, Flake DD, Mabey B, Bishoff JT, Cohen T, Stone S. Morris DS, et al. Among authors: bishoff jt. Urol Oncol. 2021 Jun;39(6):366.e19-366.e28. doi: 10.1016/j.urolonc.2020.11.016. Epub 2020 Nov 27. Urol Oncol. 2021. PMID: 33257218 Free article.
ACR appropriateness criteria post-treatment follow-up of renal cell carcinoma.
Casalino DD, Remer EM, Bishoff JT, Coursey CA, Dighe M, Harvin HJ, Heilbrun ME, Majd M, Nikolaidis P, Preminger GM, Raman SS, Sheth S, Vikram R, Weinfeld RM. Casalino DD, et al. Among authors: bishoff jt. J Am Coll Radiol. 2014 May;11(5):443-9. doi: 10.1016/j.jacr.2014.01.023. J Am Coll Radiol. 2014. PMID: 24793039
Complete embedding and close step-sectioning of radical prostatectomy specimens both increase detection of extra-prostatic extension, and correlate with increased disease-free survival by stage of prostate cancer patients.
Desai A, Wu H, Sun L, Sesterhenn IA, Mostofi FK, McLeod D, Amling C, Kusuda L, Lance R, Herring J, Foley J, Baldwin D, Bishoff JT, Soderdahl D, Moul JW. Desai A, et al. Among authors: bishoff jt. Prostate Cancer Prostatic Dis. 2002;5(3):212-8. doi: 10.1038/sj.pcan.4500600. Prostate Cancer Prostatic Dis. 2002. PMID: 12496984
Long-term health effects among testicular cancer survivors.
Hashibe M, Abdelaziz S, Al-Temimi M, Fraser A, Boucher KM, Smith K, Lee YA, Rowe K, Rowley B, Daurelle M, Holton AE, VanDerslice J, Richiardi L, Bishoff J, Lowrance W, Stroup A. Hashibe M, et al. Among authors: bishoff j. J Cancer Surviv. 2016 Dec;10(6):1051-1057. doi: 10.1007/s11764-016-0548-1. Epub 2016 May 11. J Cancer Surviv. 2016. PMID: 27169992 Free PMC article.
Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline.
Donat SM, Diaz M, Bishoff JT, Coleman JA, Dahm P, Derweesh IH, Herrell SD 3rd, Hilton S, Jonasch E, Lin DW, Reuter VE, Chang SS. Donat SM, et al. J Urol. 2013 Aug;190(2):407-16. doi: 10.1016/j.juro.2013.04.121. Epub 2013 May 7. J Urol. 2013. PMID: 23665399
73 results